JJ Wilson
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
28 févr. 2024 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and...
headshots-jj-wilson-optimi-3
Optimi Health Announces CAD $3,000,000 Senior Debt Financing
10 août 2023 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
OPTIMI Logo.png
UPDATE - Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
22 févr. 2022 10h34 HE | Optimi Health Corp.
VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
OPTIMI Logo.png
Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
22 févr. 2022 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
OPTIMI Logo.png
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
16 févr. 2022 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
OH_Logo.png
Optimi Health Strengthens Clinical and Regulatory Expertise
27 juil. 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), as part of its strategic aim to fully investigate...
OH_Logo.png
Optimi Health Completes Pre-Clinical Trial Application Meeting
15 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product developer...
OH_Logo.png
Optimi Health Announces Product Distribution Agreement with Vitasave
08 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Appoints Chief Science Officer
26 mai 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
11 mai 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...